Grant: Master's Award: Canada Graduate Scholarships
McGill University
$27,000.00
Uncovering the role of neutrophin signaling in defective synaptic refinement in cerebellar disease
EF 2024-25
Résumé
Spinocerebellar ataxia type 6 (SCA6) is a rare genetic neurodegenerative disease leading to atrophy in the cerebellum, causing motor dysfunction. Despite growing knowledge of its genetic basis, the pathophysiology of the disease remains poorly understood, which limits therapeutic options. During early development in the cerebellum, multiple climbing fibers (CFs) initially connect to Purkinje cells before synaptic pruning leaves a single CF connection. Our lab has identified a developmental delay in CF-Purkinje cell synapse elimination in a mouse model of SCA6. This suggests that developmental disruptions may contribute to the disease, even though motor symptoms manifest later in life. Brain-derived neurotrophic factor (BDNF) and its receptor, tropomyosin-related kinase B (TrkB), are essential for proper CF synapse refinement. Interestingly, both human and mouse SCA6 cerebellums exhibit reduced BDNF expression in adulthood, potentially implicating BDNF-TrkB signaling in delayed synapse refinement. My project aims to investigate the role of BDNF-TrkB signaling during cerebellar development in SCA6, hypothesizing that deficits in this pathway underlie impaired synapse elimination. To address this, I will use an enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry to characterize BDNF protein at different stages of early development in SCA6 mice and identify critical windows of BDNF deficits. I will then explore whether enhancing BDNF-TrkB signaling by administering TrkB agonist 7,8-dihydroxyflavone to pregnant and lactating dams can rescue synapse pruning deficits in SCA6 pups. This research could reveal new therapeutic strategies targeting early-stage abnormalities that may contribute to the disease, allowing for early intervention before symptom onset.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
529879
Name
Zadigue-Dubé Élyse L
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Uncovering the role of neutrophin signaling in defective synaptic refinement in cerebellar disease
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bdnf; Cerebellum; Climbing Fibers; Motor Dysfunction; Neurobiology; Neurodegeneration; Neurodevelopment; Purkinje Cell; Spinocerebellar Ataxia Type 6; Synapse Pruning
Abstract
Spinocerebellar ataxia type 6 (SCA6) is a rare genetic neurodegenerative disease leading to atrophy in the cerebellum, causing motor dysfunction. Despite growing knowledge of its genetic basis, the pathophysiology of the disease remains poorly understood, which limits therapeutic options. During early development in the cerebellum, multiple climbing fibers (CFs) initially connect to Purkinje cells before synaptic pruning leaves a single CF connection. Our lab has identified a developmental delay in CF-Purkinje cell synapse elimination in a mouse model of SCA6. This suggests that developmental disruptions may contribute to the disease, even though motor symptoms manifest later in life. Brain-derived neurotrophic factor (BDNF) and its receptor, tropomyosin-related kinase B (TrkB), are essential for proper CF synapse refinement. Interestingly, both human and mouse SCA6 cerebellums exhibit reduced BDNF expression in adulthood, potentially implicating BDNF-TrkB signaling in delayed synapse refinement. My project aims to investigate the role of BDNF-TrkB signaling during cerebellar development in SCA6, hypothesizing that deficits in this pathway underlie impaired synapse elimination. To address this, I will use an enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry to characterize BDNF protein at different stages of early development in SCA6 mice and identify critical windows of BDNF deficits. I will then explore whether enhancing BDNF-TrkB signaling by administering TrkB agonist 7,8-dihydroxyflavone to pregnant and lactating dams can rescue synapse pruning deficits in SCA6 pups. This research could reveal new therapeutic strategies targeting early-stage abnormalities that may contribute to the disease, allowing for early intervention before symptom onset.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zadigue-Dubé, Élyse L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~